Russian Federation
Russian Federation
Russian Federation
Russian Federation
Russian Federation
Different studies point to insufficient efficiency of the measures to eradicate Helicobacter pylori, and one of the reasons thereof is the patients’ low compliance to the prescribed treatment. The paper discusses the causes and the possibility of raising the patients’ adherence to anti-helicobacter therapy
Helicobacter pylori, eradication therapy, adherence to treatment
1. Malfertheiner P., Megraud F., O’Morain C. et al. Current concepts in the management of helicobacter pylori infection: the Maastricht III Consensus report // Gut. – 2007; 56: 772–781.
2. Sugano K., Tack J., Kuipers E.J. et al. Kyoto global consensus report on Helicobacter pylori gastritis // Gut. – 2015; 64: 1353–1367.
3. Ivashkin V.T., Lapina T.L., Maev I.V. i dr. Klinicheskie rekomendacii Rossiyskoy gastroenterologicheskoy associacii, Nauchnogo soobschestva po sodeystviyu klinicheskomu izucheniyu mikrobioma cheloveka, Rossiyskogo obschestva profilaktiki neinfekcionnyh zabolevaniy, Mezhregional'noy associacii po klinicheskoy mikrobiologii i antimikrobnoy himioterapii po diagnostike i lecheniyu H. pylori u vzroslyh // Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. – 2022;32(6):72–93. https://doi.org/10.22416/1382-4376- 2022-32-6-72-93
4. Maev I.V., Kucheryavyy Yu.A., Andreev D.N. Prichiny neeffektivnosti antihelikobakternoy terapii // RZhGGK. – 2013. – № 6. – S. 62–72.
5. Scherbakov P.L., Potapov A.S., Dublina E.S. i dr. Shemy eradikacii shtammov Helicobacter pylori, rezistentnyh k metronidazolu u detey // Voprosy sovremennoy pediatrii. – 2007. – T. 6. – Vyp. 5.
6. World Health Organization: adherence to long-term therapies: evidence for action 2003. http:// www.who.int/chp/knowledge/publications/ adherence_full_report.pdf
7. Osterberg L., Blaschke T. Adherence to medication // N. Engl. J. Med. – 2005; 353 (5): 487–497.
8. Kim B.J., Lee H., Lee Y.C., Jeon S.W., Kim G.H., Kim H.S. et al. Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea // Gut Liver. – 2019; 13(5): 531–40. Doi:https://doi.org/10.5009/gnl19136
9. Horne R., Weinman J., Barber N., Elliot R., Morgan M. Concordance, adherence and compliance in medicine taking // Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D. – 2005.
